搜尋結果
Eli Lilly stock hits new highs after a regulatory win in China. This is a big deal
CNBC· 11 小時前Every weekday the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" ...
Eli Lilly's diabetes drug tirzepatide gets approval in China
Reuters· 19 小時前Novo Nordisk's popular diabetes drug Ozempic won approval from China in 2021 and the ...
Council Post: 16 Important Soft Skills For Every Executive Leader To Master
Forbes· 22 小時前As they navigate the ups and downs of leading a company, executives also need to hone so-called “soft” skills such as body ...
The 8 Best Foundations With SPF That Perfect And Protect
Forbes· 22 小時前Sunscreen is essential to any good skincare routine, and makeup with SPF makes it easy to boost your sun protection. Here are our favorite ...
Hims & Hers Health to Offer Injectable Weight-Loss Drugs on Telehealth Platform
The Wall Street Journal· 2 日前The company on Monday said it now offers access to GLP-1 injections in addition to its oral ...
Hims Debuts $199 Weight-Loss Shots at 85% Discount to Wegovy
Bloomberg· 2 日前Have a confidential tip for our reporters? In just a few years, Hims & Hers Health Inc. reached ...
AstraZeneca to reduce its reliance on China, build Singapore cancer drug plant
South China Morning Post· 2 日前Antibody-drug conjugates have become an important part of Astra’s cancer push, showing the ...
The 10 Best Body Oils To Nourish And Soften Skin, According To Experts
Forbes· 2 日前From the wildly popular L’Occitane Supple Skin Body Oil to the budget-friendly SheaMoisture Coconut And Hibiscus Body Oil ...
Hims & Hers Stock Hits 3-Year High After Announcing $199 Weight-Loss Alternative To Wegovy
Forbes· 2 日前Shares of telehealth company Hims & Hers Health closed at a three-year high Monday after the ...
Innovations In Waste Processing At Lush Cosmetics
Forbes· 2 日前In an era where environmental concerns are paramount, businesses in many sectors are ...